From Chicago, at the Interscience Conference on Antimicrobial Agents and Chemotherapy
Research on a novel antibiotic offers a rare dose of optimism as existing microbe-killing compounds are losing effectiveness and the pipeline of new antibiotics is drying up.
Injections of the compound called PTK 0796 kept mice alive after they had been infected with otherwise lethal doses of Streptococcus pneumoniae, the inventors’ of the drug report.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.